Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Carcinogenesis

Abstract CN13-03: Postnatal breast involution as a highly targeted window for breast cancer prevention

Pepper J. Schedin, Jenean O'Brien, Traci Lyons, Tanya Russell and Virginia Borges
Pepper J. Schedin
University of Colorado Denver, Aurora, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenean O'Brien
University of Colorado Denver, Aurora, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Traci Lyons
University of Colorado Denver, Aurora, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Russell
University of Colorado Denver, Aurora, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Borges
University of Colorado Denver, Aurora, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1940-6207.PREV-09-CN13-03 Published January 2010
  • Article
  • Info & Metrics
Loading
Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Dec 6–9, 2009; Houston, TX

Abstract

Epidemiologic studies demonstrate a dual effect of pregnancy on breast cancer risk. Women with early age first pregnancy experience reduced breast cancer risk in their post‐menopausal years compared to nulliparous women; hence the protective effect of pregnancy. However, pregnancy transiently increases risk of breast cancer for at least ten years following parturition, thus young parous women have higher risk of breast cancer than age‐matched nulliparous women. In addition to increasing breast cancer incidence in young women, pregnancy can also negatively impact prognosis, with relative risk for death reported between 1.0–2.2, depending on age of first pregnancy. We recently proposed two distinct subtypes of PABC; breast cancer diagnosed during pregnancy and breast cancer diagnosed postpartum. This distinction is important because emerging epidemiologic data indicates worsened outcomes specific to postpartum cases. We hypothesize that postpartum PABC has poor prognosis because mammary gland involution promotes progression and metastasis of preexisting disease . Characterization of postpartum gland involution has identified tissue remodeling programs associated with wound healing, inflammation and immunosuppression including fibrillar collagen deposition, high MMP−2, −3 and−9 activities, ECM matrix proteolysis, infiltration of alternatively activated macrophages similar to tumor associated macrophages, and high levels of the M2/immunosuppressive cytokines IL‐4 and IL‐13. Thus, the postpartum involuting microenvironment, while physiologically normal, shares similarities with cancer microenvironments known to be tumor promotional. Using mammary ECM isolated from actively involuting or quiescent nulliparous glands as substratum in cell culture studies, ECM from involuting glands was found to promote breast cancer cell motility and invasion. Using two orthotopic murine xenograft models of pregnancy associated breast cancer (PABC), we demonstrate that MCF10A.DCIS cells form tumors that are larger and more metastatic when transplanted into an actively involuting mammary gland then into quiescent mammary glands of nulliparous mice. Tumors that develop in the involuting microenvironment are more likely to express the proliferative marker Ki67, to overexpress the inflammatory enzyme COX‐2 and the basal tumor cell marker p63, and to be infiltrated with thick taut collagen fibers. These data demonstrate that the promotional effects of involution on PABC can be separated from the anticipated tumor promotional effects of gestation; independently identifying the microenvironment of the involuting gland as a key determinant of tumor growth and invasiveness.

To address whether targeting involution with non‐steroidal anti‐inflammatory agents aspirin or ibuprofen could reduce the tumor promotional attributes of postpartum involution, rats were treated with 200 mg/kg dose of aspirin or 30 mg/kg dose of ibuprofen starting on the day of weaning and continuing for 6 days post weaning. Drug treatments did not inhibit normal alveolar regression that occurs with involution. However, mammary ECM isolated from involuting glands of rats treated with aspirin or ibuprofen was found to phenocopy tumor‐suppressive nulliparous mammary ECM in 3D culture of transformed mammary epithelial cells. These data suggest that aspirin and ibuprofen reduce the pro‐inflammatory microenvironment of postpartum involution consistent with tumor suppression. To evaluate whether targeting involution could reduce the tumor promotional effects of involution in vivo, mice were treated with ibuprofen starting on the day of weaning and continued for 2 weeks, such that treatment was limited to the involution window. MCF10A.DCIS cells were injected into the involuting glands one day post weaning and tumor growth characterized for 6 weeks. Average tumor growth was decreased in mice with ibuprofen treatment during involution compared to the control‐involution group. Further, tumor size in the ibuprofen‐involution group was reduced to similar tumor size as observed in the control‐nulliparous group.

These data demonstrate that postpartum mammary gland involution is characterized by a pro‐inflammatory microenvironment, implicating physiologic tissue inflammation in the poor prognosis of PABC. Likewise, in two new murine models for PABC, involution is associated with increased tumor invasion and metastasis. Finally, these data identify the window of postpartum gland involution as a potential target for chemoprevention.

Citation Information: Cancer Prev Res 2010;3(1 Suppl):CN13-03.

  • Copyright © January 7, 2010, American Association for Cancer Research
Previous
Back to top
January 2010
Volume 3, Issue 1 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract CN13-03: Postnatal breast involution as a highly targeted window for breast cancer prevention
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract CN13-03: Postnatal breast involution as a highly targeted window for breast cancer prevention
Pepper J. Schedin, Jenean O'Brien, Traci Lyons, Tanya Russell and Virginia Borges
Cancer Prev Res January 7 2010 (3) (1 Supplement) CN13-03; DOI: 10.1158/1940-6207.PREV-09-CN13-03

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract CN13-03: Postnatal breast involution as a highly targeted window for breast cancer prevention
Pepper J. Schedin, Jenean O'Brien, Traci Lyons, Tanya Russell and Virginia Borges
Cancer Prev Res January 7 2010 (3) (1 Supplement) CN13-03; DOI: 10.1158/1940-6207.PREV-09-CN13-03
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Carcinogenesis

  • Abstract B21: The effect of mutant Kras associated changes in redox signaling in pancreatic neoplasia.
  • Abstract B22: The role of e-cigarette exposure on pulmonary epithelial cell transformation
  • Abstract B18: Thrombospondin-1 regulates carcinogenesis in an in vivo model of colorectal cancer
Show more Carcinogenesis

Oral Presentations - Invited Abstracts

  • Abstract IA18: The exposome and cancer
  • Abstract IA17: Challenges and opportunities in environmental carcinogenesis: The NIEHS perspective
  • Abstract IA24: Applying epidemiology to prevention
Show more Oral Presentations - Invited Abstracts

Invited Abstracts - Stromal Targets for Breast Cancer Prevention

  • Abstract CN13-04: Obesity, insulin resistance, hyperglycemia, and cancer: A novel role for metformin as an anticancer drug
  • Abstract CN13-05: A new resource to accelerate research into the cause and prevention of breast cancer: The Love/Avon Army of Women
Show more Invited Abstracts - Stromal Targets for Breast Cancer Prevention
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement